Lower levels of Caveolin-1 and higher levels of endothelial nitric oxide synthase are observed in abdominal aortic aneurysm patients treated with simvastatin

• Authors: Karolina Kowalska , Dominika Habrowska-Górczyńska , Christoph Neumayer , Michael Bolliger , Christoph Domenig , Agnieszka Piastowska-Ciesielska , Ihor Huk , Aleksandra Piechota-Polanczyk
• Languages of publication: EN

Abstracts

EN

This study was undertaken to verify whether simvastatin modulates Cav-1/eNOS expression, and if this modulation is associated with changes in pro- and anti-inflammatory cytokine and Toll-like receptor 4 (TLR4) level in abdominal aortic aneurysm (AAA). It is a 1:2 case-control study of non-statin (n=12) and simvastatin-treated patients (n=24) who underwent open AAA repair. Simvastatin treatment decreased Cav-1 (p<0.05) and increased eNOS expression (p<0.01) in the AAA wall. These changes might be dose dependent. The changes in Cav-1 and eNOS were associated with a trend towards decreased IL-6 and IL-17 concentration (p>0.05) and increased IL-10 concentration (p=0.055); however, TLR4 expression was unaffected, suggesting that simvastatin influences Cav-1 and eNOS in the AAA wall by other mechanisms. Simvastatin may modulate Cav-1 and eNOS expression in the aneurysmal wall, indicating a potentially beneficial role for statins in AAA patients.

Keywords

EN

Cav-1; eNOS; abdominal aortic aneurysm; simvastatin

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2018
• Volume: 65
• Issue: 1
• Pages: 111-118

Dates

published

2018

received

2017-08-23

revised

2018-02-17

accepted

2018-03-01

(unknown)

2018-03-15

Contributors

author

Karolina Kowalska

• Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria
• Laboratory of Cell Cultures and Genomic Analysis, Department of Comparative Endocrinology, Medical University of Lodz, Łódź, Poland

author

Dominika Habrowska-Górczyńska

• Laboratory of Cell Cultures and Genomic Analysis, Department of Comparative Endocrinology, Medical University of Lodz, Łódź, Poland

author

Christoph Neumayer

• Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria

author

Michael Bolliger

• Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria

author

Christoph Domenig

• Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria

author

Agnieszka Piastowska-Ciesielska

• Laboratory of Cell Cultures and Genomic Analysis, Department of Comparative Endocrinology, Medical University of Lodz, Łódź, Poland

author

Ihor Huk

• Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria

author

Aleksandra Piechota-Polanczyk

• Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland

References

• Almansob MA, Xu B, Zhou L, Hu XX, Chen W, Chang FJ, Ci HB, Yao JP, Xu YQ, Yao FJ, Liu DH, Zhang WB, Tang BY, Wang ZP, Ou JS (2012a) Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol 32: 2304-2313. doi: 10.1161/ATVBAHA.112.252098.
• Arora R, Hare DL, Zulli A (2012) Simvastatin reduces endothelial NOS: caveolin-1 ratio but not the phosphorylation status of eNOS in vivo. J Atheroscler Thromb 19: 705-711.
• Azor MH, dos Santos JC, Futata EA, de Brito CA, Maruta CW, Rivitti EA, da Silva Duarte AJ, Sato MN (2011) Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria. Clin Exp Immunol 166: 291-298. doi: 10.1111/j.1365-2249.2011.04473.x.
• Chen G, Zhang S, Shi J, Ai J, Qi M, Hang C (2009) Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 216: 398-406. doi: 10.1016/j.expneurol.2008.12.019.
• Chen Y, Zhang S, Peng G, Yu J, Liu T, Meng R, Li Z, Zhao Y, Wu G (2013) Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: pleiotropic and dose-dependent effect on tumor vascular stabilization. Int J Oncol 42: 1325-1336. doi: 10.3892/ijo.2013.1833.
• Ching LC, Kou YR, Shyue SK, Su KH, Wei J, Cheng LC, Yu YB, Pan CC, Lee TS (2011) Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc Res 91: 492-501. doi: 10.1093/cvr/cvr104.
• Chow AK, Cena J, El-Yazbi AF, Crawford BD, Holt A, Cho WJ, Daniel EE, Schulz R (2007) Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. J Mol Cell Cardiol 42: 896-901. doi: 10.1016/j.yjmcc.2007.01.008.
• Evans J, Powell JT, Schwalbe E, Loftus IM, Thompson MM (2007) Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg 34: 302-303. doi: 10.1016/j.ejvs.2007.04.011.
• Gao L, Siu KL, Chalupsky K, Nguyen A, Chen P, Weintraub NL, Galis Z, Cai H (2012) Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 59: 158-166. doi: 10.1161/HYPERTENSIONAHA.111.181644.
• Heeba G, Hassan MK, Khalifa M, Malinski T (2007) Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins. J Cardiovasc Pharmacol 50: 391-398. doi: 10.1097/FJC.0b013e31811f3fd0.
• Hou HH, Liao YJ, Hsiao SH, Shyue SK, Lee TS (2015) Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase. Sci Rep 5: 13524. doi: 10.1038/srep13524.
• Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, Malinski T (1997) L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96: 667-675.
• Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC (1991) Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13: 452-458.
• Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, Upchurch GR Jr, Ailawadi G (2013) Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 33: 294-304. doi: 10.1161/ATVBAHA.112.300432.
• Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, Powell JT (2001) Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103: 2260-2265.
• Kanai AJ, Strauss HC, Truskey GA, Crews AL, Grunfeld S, Malinski T (1995) Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ Res 77: 284-293.
• Kokje VB, Hamming JF, Lindeman JH (2015) Editor's choice - pharmaceutical management of small abdominal aortic aneurysms: a systematic review of the clinical evidence. Eur J Vasc Endovasc Surg 50: 702-713. doi: 10.1016/j.ejvs.2015.08.010.
• Kowalska K, Nowakowska M, Dominska K, Piastowska-Ciesielska AW (2016) Coexpression of CAV-1, AT1-R and FOXM1 in prostate and breast cancer and normal cell lines and their influence on metastatic properties. Acta Biochim Pol 63: 493-499. doi: 10.18388/abp.2015_1016.
• Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104: 448-454.
• Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, Dulak J (2006) Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis 187: 26-30. doi: 10.1016/j.atherosclerosis.2006.03.015.
• Mastoraki ST, Toumpoulis IK, Anagnostopoulos CE, Tiniakos D, Papalois A, Chamogeorgakis TP, Angouras DC, Rokkas CK (2012) Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits. Ann Vasc Surg 26: 250-258. doi: 10.1016/j.avsg.2011.09.003.
• Meda C, Plank C, Mykhaylyk O, Schmidt K, Mayer B (2010) Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells. Pharmacol Rep 62: 100-112.
• Mirza MK, Yuan J, Gao XP, Garrean S, Brovkovych V, Malik AB, Tiruppathi C, Zhao YY (2010) Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am J Pathol 176: 2344-2351. doi: 10.2353/ajpath.2010.091088.
• Moutzouri E, Tellis CC, Rousouli K, Liberopoulos EN, Milionis HJ, Elisaf MS, Tselepis AD (2012) Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide-induced cytokine production in monocytes of hypercholesterolemic patients. Atherosclerosis 225: 381-387. doi: 10.1016/j.atherosclerosis.2012.08.037.
• Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K, Wolzt M, Wojta J (2006) Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 189: 408-413. doi: 10.1016/j.atherosclerosis.2005.12.022.
• Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
• Piechota-Polanczyk A, Goraca A, Demyanets S, Mittlboeck M, Domenig C, Neumayer C, Wojta J, Nanobachvili J, Huk I, Klinger M (2012) Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-kappaB. Eur J Vasc Endovasc Surg 44: 133-137. doi: 10.1016/j.ejvs.2012.04.020.
• Piechota-Polanczyk A, Demyanets S, Nykonenko O, Huk I, Mittlboeck M, Domenig CM, Neumayer C, Wojta J, Nanobachvili J, Klinger M (2013) Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 45: 682-688. doi: 10.1016/j.ejvs.2013.02.015.
• Piechota-Polanczyk A, Demyanets S, Mittlboeck M, Hofmann M, Domenig CM, Neumayer C, Wojta J, Klinger M, Nanobachvili J, Huk I (2015a) The influence of simvastatin on NGAL, matrix metalloproteinases and their tissue inhibitors in human intraluminal thrombus and abdominal aortic aneurysm tissue. Eur J Vasc Endovasc Surg 49: 549-555. doi: 10.1016/j.ejvs.2015.02.011.
• Piechota-Polanczyk A, Jozkowicz A, Nowak W, Eilenberg W, Neumayer C, Malinski T, Huk I, Brostjan C (2015b) The Abdominal aortic aneurysm and intraluminal thrombus: current concepts of development and treatment. Front Cardiovasc Med 2: 19. doi: 10.3389/fcvm.2015.00019.
• Ricchiuti V, Lapointe N, Pojoga L, Yao T, Tran L, Williams GH, Adler GK (2011) Dietary sodium intake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling proteins in heart. J Endocrinol 211: 47-54. doi: 10.1530/JOE-10-0458.
• Shao H, Shen Y, Liu H, Dong G, Qiang J, Jing H (2007) Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model. Ann Thorac Surg 84: 2011-2018. doi: 10.1016/j.athoracsur.2007.07.022.
• Singh P, Peterson TE, Sert-Kuniyoshi FH, Jensen MD, Somers VK (2011) Leptin upregulates caveolin-1 expression: implications for development of atherosclerosis. Atherosclerosis 217: 499-502. doi: 10.1016/j.atherosclerosis.2010.10.012.
• Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY (2006) Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114: 2655-2662. doi: 10.1161/CIRCULATIONAHA.106.630194.
• Takayama T, Yamanouchi D (2013) Aneurysmal disease: the abdominal aorta. Surg Clin North Am 93: 877-891. doi: 10.1016/j.suc.2013.05.005.
• Takayanagi T, Crawford KJ, Kobayashi T, Obama T, Tsuji T, Elliott KJ, Hashimoto T, Rizzo V, Eguchi S (2014) Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase. Clin Sci (Lond) 126: 785-794. doi: 10.1042/CS20130660.
• Testa A, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, Tripepi G, Benedetto FA, Mallamaci F, Zoccali C (2012) eNOS and caveolin-1 gene polymorphisms interaction and intima media thickness: a proof of concept study in ESRD patients. Am J Hypertens 25: 103-108. doi: 10.1038/ajh.2011.178.
• Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM (2009) The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 182: 3809-3818. doi: 10.4049/jimmunol.0712437.
• Weiss CR, Guan Q, Ma Y, Qing G, Bernstein CN, Warrington RJ, Peng Z (2015) The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis. PLoS One 10: e0119004. doi: 10.1371/journal.pone.0119004.

Identifiers

DOI

10.18388/abp.2017_2305